Body Fluids News and Research

RSS

Two new retroviruses among central Africans who hunt nonhuman primates

A team of researchers from the Johns Hopkins Bloomberg School of Public Health, the Centers for Disease Control and Prevention (CDC), and the Army Health Research Center (CRESAR) in Cameroon have discovered two new retroviruses among central Africans who hunt nonhuman primates.

16 May 2005

BMA calls for mass child vaccinations for hepatitis B virus (HBV)

The British Medical Association (BMA) has today called for all children in the UK to be immunised against a potentially fatal liver disease caused by the hepatitis B virus (HBV).

9 May 2005

Marburg virus - 275 confirmed cases

The World Health Organization (WHO) and health authorities in Angola have confirmed 275 cases including 255 deaths, in an outbreak of Marburg virus in north-western Angola since April 27 this year.

2 May 2005

Runners must hydrate properly

Seeking to clarify complex issues involving hydration for athletes, the American College of Sports Medicine (ACSM) today reiterated its statements on hyponatremia and dehydration for athletes during endurance events.

27 Apr 2005

Marburg outbreak appears to be under control at last

Medical teams attempting to control the worst outbreak ever recorded of the deadly Marburg virus in Angola are beginning to see the light at the end of the tunnel as cooperation from stricken communities improves, the U.N. health agency said.

25 Apr 2005

CDC experts sent to Angola to help with Marburg epidemic

In an effort to control the Marburg virus outbreak in Angola, Health officials from the Centers for Disease Control and Prevention in Atlanta will assist the World Health Organization by going to Angola to help with outbreak investigation, infection control and laboratory diagnosis of the disease.

30 Mar 2005

Degradable glass to help new bone growth

The University of Kent is collaborating with research teams from the University of Warwick, Imperial College London and University College London (UCL) to develop novel forms of degradable glass for a variety of medical applications, including new bone growth.

23 Mar 2005

New study to evaluate Pegasys and Copegus to treat hepatitis C in liver transplant patients

Roche has initiated a new study to evaluate treatment strategies to reduce post-transplant recurrence of hepatitis C infection with the most prescribed hepatitis C treatment combination in the U.S., Pegasys (peginterferon alfa-2a) and Copegus (ribavirin, USP).

21 Mar 2005

New hepatitis drug wins approval by FDA

An experimental hepatitis B drug has earned the praise of US health experts for its effectiveness and has been recommended by the US Food and Drug Administration (FDA) advisory panel to treat the liver disease in adults.

14 Mar 2005

Angiogenesis inhibitor molecules defend against the development and spread of cancer

Research led by investigators at Beth Israel Deaconess Medical Center (BIDMC) helps explain how a group of angiogenesis inhibitor molecules serve as an important defense mechanism against the development and spread of cancer, offering key insights into why cancerous tumors grow at different rates among different individuals.

15 Feb 2005

Natural honey-bee products may have applications in cancer treatment

Natural honey-bee products such as propolis, royal jelly, caffeic acid, honey and venom may have applications in cancer treatment and prevention, say Croatian researchers in Journal of the Science of Food and Agriculture this month.

3 Dec 2004

Positive results of study with human lactoferrin

Pharming Group N.V. announced today the positive results from a key study with recombinant human lactoferrin (rhLF). The Company will use these results for Generally Regarded as Safe (GRAS) registration of rhLF for nutritional applications.

24 Nov 2004

New molecular tool to pinpoint DNA mutations among thousands of cells

Scientists have designed a new molecular tool, dubbed "LigAmp," to pinpoint DNA mutations among thousands of cells, the equivalent of searching for a single typo in an entire library of books.

28 Oct 2004

Clearing toxins in the brains of Alzheimer's patients can stave off future reductions in cognitive abilities

The ever-slowing capacity to clear the build-up of such toxins as isoprostanes and misfolded proteins that accumulate in the brains of Alzheimer's disease patients causes the death of cells involved in memory and language.

23 Aug 2004

Friendly bacteria the key to ulcerative colitis treatment

Affecting an estimated fifty thousand people in the UK, with a particularly high incidence rate in north east Scotland, ulcerative colitis is an acute and chronic disease that causes inflammation and sores, called ulcers, in the lining of the large bowel.

17 Aug 2004

New service-oriented laboratory focused on bioanalysis and pharmacokinetics

Oregon Health & Science University researchers will more quickly move benchtop discoveries toward drug discoveries with the help of a new, service-oriented laboratory focused on bioanalysis and pharmacokinetics.

11 Aug 2004

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.

5 Aug 2004

Pacemakers and defibrillators can be safe for use in magnetic resonance imaging machines

In animal and laboratory studies, scientists at Johns Hopkins have shown that modern, implanted heart assist devices - such as pacemakers and defibrillators - can be safe for use in magnetic resonance imaging (MRI) machines

3 Aug 2004

Fine tuning your loss of body fluids may be more problematic now that researchers find receptors have an active role in our sweat rate

For most of us, hot weather leads to elevated internal and skin temperatures, which increase sweat rates and skin blood flow. How much we sweat can also depend on nonthermal factors such as exercise, baroreceptor loading status, and body fluid status.

21 Jul 2004

Melanotan-1 can induce tanning in human volunteers who are known to tan easily in response to sunlight

An article in the July issue of the Archives of Dermatology reports that Melanotan-1, a synthetic agent similar to the body's hormone that regulates skin pigmentation, can be combined with UV-B light or sunlight, and appears to act synergistically in the tanning response to light.

20 Jul 2004